Joohyuk Sohn - Dissemin

All papers authored by Joohyuk Sohn

This paper was not found in any repository, but could be made available legally by the author.

2023 Se Hyun Kim

, Seock-Ah Im, Koung Jin Suh

, Kyung-Hun Lee

, Min Hwan Kim, Joohyuk Sohn

, Yeon Hee Park, Ji-Yeon Kim, Jae Ho Jeong, Kyoung Eun Lee

, In Sil Choi

, Kyong Hwa Park

, Hee-Jun Kim

, Eun Kyung Cho, So Yeon Park

and 2 other authors

Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)

Upload

2022 Shanu Modi, William Jacot, Toshinari Yamashita, Joohyuk Sohn

, Maria Vidal, Eriko Tokunaga, Junji Tsurutani, Naoto T. Ueno, Aleix Prat, Yee Soo Chae, Keun Seok Lee, Naoki Niikura, Yeon Hee Park, Binghe Xu, Xiaojia Wang and 23 other authors

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Upload

This paper is made freely available by the publisher.

Francois-Clement Bidard, Virginia G. Kaklamani

, Patrick Neven, Guillermo Streich, Alberto J. Montero

, Frédéric Forget, Marie-Ange Mouret-Reynier, Joo Hyuk Sohn

, Donatienne Taylor

, Kathleen K. Harnden

, Hung Khong

, Judit Kocsis, Florence Dalenc, Patrick M. Dillon

, Sunil Babu and 14 other authors

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

Download from doi.org

2021 J. Ángel García Sáenz, J. Zarba, N. Harbeck, P. Rastogi, M. Martin, S. M. Tolaney, Z. M. Shao, P. A. Fasching, M. Andersson, C. S. Huang, G. G. Jaliffe, G. F. Fleming, A. Tryakin

, M. P. Goetz, H. S. Rugo and 72 other authors

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Kyung-Hun Lee, Joohyuk Sohn

, Annabel Goodwin, Tiziana Usari, Silvana Lanzalone, Seock-Ah Im, Sung-Bae Kim

Talazoparib Versus Chemotherapy in Patients with HER2-negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA Trial

Upload

Won-Ji Ryu

, Joo Hyuk Sohn

Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer

Download from doi.org

Bradley J. Monk, Nicoletta Colombo, Amit M. Oza, Keiichi Fujiwara, Michael J. Birrer, Leslie Randall, Elena V. Poddubskaya, Giovanni Scambia, Yaroslav V. Shparyk, Myong Cheol Lim, Snehalkumar M. Bhoola, Joohyuk Sohn

, Kan Yonemori, Ross A. Stewart, Xiaoxi Zhang and 4 other authors

Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial

Upload

Patrick Neven, Stephen R. D. Johnston, Masakazu Toi

, Joohyuk Sohn

, Kenichi Inoue, Xavier Pivot, Olga Burdaeva, Meena Okera, Norikazu Masuda

, Peter A. Kaufman, Han Koh, Eva-Maria Grischke, PierFranco Conte

, Yi Lu

, Nadine Haddad and 3 other authors

MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant as First-Line and Second-Line Therapy for HR+, HER2−-Advanced Breast Cancer

Upload

Aditya Bardia, Fei Su, Nadia Solovieff, Seock-Ah Im

, Joohyuk Sohn

, Keun Seok Lee, Saul Campos-Gomez

, Kyung Hae Jung, Marco Colleoni, Rafael Villanueva Vázquez, Fabio Franke, Sara Hurvitz

, Nadia Harbeck

, Louis Chow, Tetiana Taran and 5 other authors

Genomic Profiling of Premenopausal HR+ and HER2– Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and Ribociclib

Download from doi.org

Hwa Kyung Byun, Jee Suk Chang, Sang Hee Im, Youlia M. Kirova, Alexandre Arsene-Henry, Seo Hee Choi, Young Up Cho, Hyung Seok Park, Jee Ye Kim, Chang-Ok Suh, Ki Chang Keum, Joo Hyuk Sohn

, Gun Min Kim, Ik Jae Lee, Jun Won Kim

and 1 other authors

Risk of Lymphedema Following Contemporary Treatment for Breast Cancer: An Analysis of 7617 Consecutive Patients From a Multidisciplinary Perspective

Upload

Stephen Johnston, Joyce O’Shaughnessy, Miguel Martin, Jens Huober, Masakazu Toi

, Joohyuk Sohn

, Valérie A. M. André, Holly R. Martin, Molly C. Hardebeck, Matthew P. Goetz

Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups

Download from doi.org

Hye Yoon Park, Hyeongrae Lee, Joohyuk Sohn

, Suk Kyoon An, Kee Namkoong, Eun Lee

Increased resting-state cerebellar-cortical connectivity in breast cancer survivors with cognitive complaints after chemotherapy

Download from doi.org

Soong June Bae, Jee Hung Kim, Sung Gwe Ahn, Hei-Cheul Jeung, Joohyuk Sohn

, Gun Min Kim, Min Hwan Kim, Seung Il Kim, Seho Park, Hyung Seok Park, Ji Ye Kim, Joon Jeong

Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer

Download from doi.org

Sun Min Lim, Eunyoung Kim

, Kyung Hae Jung, Sora Kim, Ja Seung Koo, Seung Il Kim, Seho Park, Hyung Seok Park, Byoung Woo Park, Young Up Cho

, Ji Ye Kim, Soonmyung Paik

, Nak-Jung Kwon, Gun Min Kim, Ji Hyoung Kim

and 4 other authors

Genomic landscape of extraordinary responses in metastatic breast cancer

Download from doi.org

Jii Bum Lee, Minkyu Jung, Seung Hoon Beom, Gun Min Kim, Hye Ryun Kim, Hye Jin Choi, Joo Hyuk Sohn

, Joong Bae Ahn, Sun Young Rha, Hyun Cheol Chung

Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations

Upload

Jae Ho Jeong

, Jeong Eun Kim

, Jin-Hee Ahn, Kyung Hae Jung, Su-Jin Koh

, Jaekyung Cheon, Joohyuk Sohn

, Gun Min Kim, Keun Seok Lee, Sung Hoon Sim, In Hae Park, Sung-Bae Kim

Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO study

Upload

A. Brufsky, S. B. Kim, Ž. Zvirbule, A. Eniu, J. Mebis, J. H. Sohn

, M. Wongchenko, S. Chohan, R. Amin, Y. Yan, V. McNally, D. Miles, S. Loi

A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis

Upload

Sung-Bae Kim, Jae Hong Seo, Jin-Hee Ahn, Tae-Yong Kim, Seok Yun Kang, Joohyuk Sohn

, Yaewon Yang, Kyong Hwa Park, Yong Wha Moon, Seungtaek Lim, Myoung Joo Kang, Koung Eun Yoon, Hyun Ju Cho, Keun Seok Lee

Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)

Download from doi.org

2020 Elizabeth A. Mittendorf, Hong Zhang, Carlos H. Barrios, Shigehira Saji, Kyung Hae Jung, Roberto Hegg, Andreas Koehler, Joohyuk Sohn

, Hiroji Iwata, Melinda L. Telli, Cristiano Ferrario, Kevin Punie, Frédérique Penault-Llorca, Shilpen Patel, Anh Nguyen Duc and 5 other authors

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

Upload

Ji-Yeon Kim, Kyunghee Park, Seock-Ah Im, Kyung Hae Jung, Joohyuk Sohn

, Keun Seok Lee, Jee Hyun Kim, Yaewon Yang, Yeon Hee Park

Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Joohyuk Sohn